12th Nottingham Barrett’s Endotherapy Course - Thursday 27th June 2024

Instead of conventional lectures we have designed five debates covering all current hot topics in Barrett's endotherapy at the moment: new tissue acquisition devices, artificial intelligence (AI), the role of ESD, the endoscopic management of submucosal cancers and current controversies around ablation therapies. This will be complemented with some training videos to explain tips and tricks on how to perform high quality diagnostic endoscopy in Barrett’s, EMR and RFA and the whole panel of experts commenting on the live cases from our endoscopy unit. The aim is to create dynamic, open and interactive discussions covering all the known and the new aspects of the endoscopic treatment for early Barrett's neoplasia.

Sponsored breakout sessions by our Gold and Silver sponsors

Separate booking required at no extra fee

SESSION 1

Alternative ablation methods for early Barrett’s neoplasia – Role of Cryoablation: Indications, technique and outcomes

Speaker: Vinay Sehgal, Consultant Gastroenterologist, University College Hospital London

Sponsored by PENTAX

SESSION 2

Is there any way to prevent post ESD oesophageal strictures? – Injecting steroids, swallowing steroids and current research on some new options. Potential role of Purastat™

Speaker: Max Barret

Sponsored by AQUILANT/3D MATRIX

SESSION 3

OverStitch Sx™ and other endoscopic suturing devices – Bariatric endoscopy, endoscopic anti reflux treatment and closure of post ESD defects

Speaker: Roberta Maselli

Sponsored by BOSTON SCI

SESSION 4

New ESGE guidelines now recommend non-endoscopic capsule sponge test as a valid alternative to endoscopy in detecting Barrett's: Are there any other potential indications? – Current evidence and ongoing research

Speaker: Massi di Pietro

Sponsored by CYTED

SESSION 5

Advanced imaging techniques in the diagnosis and treatment of early UGI neoplasia: EDOF, NBI, TXI and more – When to use and how to get out the most of them

Speaker: Krish Ragunath

Sponsored by OLYMPUS

Sponges, brushes and other new tissue acquisition devices: Is there a paradigm shift in how to diagnose Barrett’s? Are we ready to screen the population?

• Yes, the new kids on the block are changing the game - Ian Penman

• No, they are just one more tool in your belt - Nastazja Pilonis

Moderator: Massi di Pietro

Cancer risk stratification in non-dysplastic Barrett's oesophagus: Biomarkers and conventional risk factors– Can we tailor surveillance to individual risk?

• Yes, nearly there - Massi di Pietro

• No, still a long way to go - Helen Coleman

• Nevermind, now is the time to completely stop surveillance - Roos Pouw

Moderator: Nastazja Pilonis

EMR Practical Session

How and when to perform an EMR. Tips and Tricks. Common mistakes and how to avoid them

Francisco Baldaque-Silva

11:45 - 12:15

Live Case 1 - EMR: Indications, technique, tips and tricks

Guiomar Moral and Krish Ragunath

Moderator: Francisco Baldaque-Silva

Whole faculty panel commenting on

RFA Practical Session

How and when to perform RFA. Tips and Tricks. Common mistakes and how to avoid them

Glòria Fernández-Esparrach

12:30 - 13:00

Life case 2 - RFA

Guiomar Moral and Krish Ragunath

Moderator: Glòria Fernández-Esparrach

Whole faculty panel commenting on

Be prepared to see your endoscopist every 3 months for quite a few years. Impact of the doctor-patient relationship in the treatment outcomes and how to build that up - The patient's view.

Michael Lindsay and Bernard McGuirk

Should we adopt a less is more strategy in Barrett's endotherapy? Resection alone of visible neoplasia vs. Conventional stepwise resection + ablation regime

• Yes, the minimalist endoscopist - Raf Bisschops

• No, if it works…don’t touch it! - Max Barret

Moderator: Ian Penman

ESD is finally in the guidelines!– But still all about endoscopist’s ego or a real game changing technique?

Roberta Maselli

Endoscopy is now well established as the first line treatment for dysplastic Barrett's and intramucosal adenocarcinoma: Can we go deeper and cure T1b cancers? Is all about the depth? Other histological risk factors for nodal disease

• Yes, super-endoscopist to the rescue - Roos Pouw

• No, you still need us, your friendly neighbourhood - James Catton

Moderator: Raf Bisschops

Summary of the day and take home messages

Andy Cole